Literature DB >> 4030103

Lymphokine activation of J774G8 cells and mouse peritoneal macrophages challenged with Toxoplasma gondii.

L D Sibley, J L Krahenbuhl, E Weidner.   

Abstract

In vitro activation of macrophage cell line J774G8 and mouse peritoneal macrophages resulted in oxygen-dependent and oxygen-independent killing of intracellular Toxoplasma gondii. Activation was characterized by oxygen-dependent killing detectable by enhanced lysosome fusion and digestion of T. gondii. The toxoplasmacidal activity of activated J774G8 cells and peritoneal macrophages was prevented by adding the oxygen intermediate scavengers catalase or superoxide dismutase during culture. Activated J774G8 cells and peritoneal macrophages also inhibited replication of those Toxoplasma organisms which survived the initial microbicidal activity. The inhibition of Toxoplasma replication was not significantly affected by exogenous catalase or superoxide dismutase. Peritoneal macrophages from Toxoplasma-immune mice showed similar microbicidal and inhibitory responses, supporting the model that activation leads to destruction of intracellular parasites by two different mechanisms.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4030103      PMCID: PMC261267          DOI: 10.1128/iai.49.3.760-764.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Lymphocyte-macrophage interaction during control of intracellular parasitism.

Authors:  T C Jones; H Masur; L Len; T L Fu
Journal:  Am J Trop Med Hyg       Date:  1977-11       Impact factor: 2.345

2.  Induction of resistance to Toxoplasma gondii in human macrophages by soluble lymphocyte products.

Authors:  S E Anderson; S Bautista; J S Remington
Journal:  J Immunol       Date:  1976-08       Impact factor: 5.422

3.  Macrophage tumor killing: influence of the local environment.

Authors:  J B Hibbs; R R Taintor; H A Chapman; J B Weinberg
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

4.  A role for activated macrophages in resistance to infection with Toxoplasma.

Authors:  J S Remington; J L Krahenbuhl; J W Mendenhall
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

5.  Resistance to murine tumors conferred by chronic infection with intracellular protozoa, Toxoplasma gondii and Besnoitia jellisoni.

Authors:  J B Hibbs; L H Lambert; J S Remington
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

6.  Development of gametes and oocysts in cats fed cysts derived from cloned trophozoites of Toxoplasma gondii.

Authors:  E R Pfefferkorn; L C Pfefferkorn; E D Colby
Journal:  J Parasitol       Date:  1977-02       Impact factor: 1.276

7.  Inhibition of growth of Toxoplasma gondii in cultured fibroblasts by human recombinant gamma interferon.

Authors:  E R Pfefferkorn; P M Guyre
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

8.  Immunity to Toxoplasma gondii induced in vitro in non-immune mouse macrophages with specifically immune lymphocytes.

Authors:  K K Sethi; B Pelster; N Suzuki; G Piekarski; H Brandis
Journal:  J Immunol       Date:  1975-10       Impact factor: 5.422

9.  Effect of normal and activated human macrophages on Toxoplasma gondii.

Authors:  S E Anderson; J S Remington
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

10.  Assessment in vitro of immunity against Toxoplasma gondii.

Authors:  T C Jones; L Len; J G Hirsch
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

View more
  11 in total

1.  Dendritic cells as effector cells: gamma interferon activation of murine dendritic cells triggers oxygen-dependent inhibition of Toxoplasma gondii replication.

Authors:  F Aline; D Bout; I Dimier-Poisson
Journal:  Infect Immun       Date:  2002-05       Impact factor: 3.441

Review 2.  Lytic cycle of Toxoplasma gondii.

Authors:  M W Black; J C Boothroyd
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

3.  Nonoxidative microbicidal activity in normal human alveolar and peritoneal macrophages.

Authors:  J R Catterall; C M Black; J P Leventhal; N W Rizk; J S Wachtel; J S Remington
Journal:  Infect Immun       Date:  1987-07       Impact factor: 3.441

4.  Induction of unresponsiveness to gamma interferon in macrophages infected with Mycobacterium leprae.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

5.  Inhibition of the intracellular growth of Histoplasma capsulatum by recombinant murine gamma interferon.

Authors:  B A Wu-Hsieh; D H Howard
Journal:  Infect Immun       Date:  1987-04       Impact factor: 3.441

6.  Mycobacterium leprae-burdened macrophages are refractory to activation by gamma interferon.

Authors:  L D Sibley; J L Krahenbuhl
Journal:  Infect Immun       Date:  1987-02       Impact factor: 3.441

7.  Regulation of murine macrophage effector functions by lipoarabinomannan from mycobacterial strains with different degrees of virulence.

Authors:  L B Adams; Y Fukutomi; J L Krahenbuhl
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Intracellular fate of Mycobacterium leprae in normal and activated mouse macrophages.

Authors:  L D Sibley; S G Franzblau; J L Krahenbuhl
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

9.  Oxygen-independent killing by alveolar macrophages.

Authors:  J R Catterall; S D Sharma; J S Remington
Journal:  J Exp Med       Date:  1986-05-01       Impact factor: 14.307

10.  Toxoplasma modifies macrophage phagosomes by secretion of a vesicular network rich in surface proteins.

Authors:  L D Sibley; J L Krahenbuhl; G M Adams; E Weidner
Journal:  J Cell Biol       Date:  1986-09       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.